Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Veterinary Antibiotics Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Veterinary Antibiotics Industry
  • 1.7 COVID-19 Impact: Veterinary Antibiotics Market Trends

    • 2 Global Veterinary Antibiotics Quarterly Market Size Analysis

    • 2.1 Veterinary Antibiotics Business Impact Assessment - COVID-19
      • 2.1.1 Global Veterinary Antibiotics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Veterinary Antibiotics Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Veterinary Antibiotics Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Veterinary Antibiotics Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Veterinary Antibiotics Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Veterinary Antibiotics Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Veterinary Antibiotics Market
    • 3.5 Key Manufacturers Veterinary Antibiotics Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Veterinary Antibiotics Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Tetracyclines
      • 1.4.2 Penicillins
      • 1.4.3 Macrolides
      • 1.4.4 Sulphonamides
      • 1.4.5 Aminoglycosides
      • 1.4.6 Others
    • 4.2 By Type, Global Veterinary Antibiotics Market Size, 2019-2021
      • 4.2.1 By Type, Global Veterinary Antibiotics Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Veterinary Antibiotics Price, 2020-2021

    5 Impact of Covid-19 on Veterinary Antibiotics Segments, By Application

    • 5.1 Overview
      • 5.5.1 Farm Animals
      • 5.5.2 Companion Animals
    • 5.2 By Application, Global Veterinary Antibiotics Market Size, 2019-2021
      • 5.2.1 By Application, Global Veterinary Antibiotics Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Veterinary Antibiotics Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Zoetis animal healthcare
      • 7.1.1 Zoetis animal healthcare Business Overview
      • 7.1.2 Zoetis animal healthcare Veterinary Antibiotics Quarterly Production and Revenue, 2020
      • 7.1.3 Zoetis animal healthcare Veterinary Antibiotics Product Introduction
      • 7.1.4 Zoetis animal healthcare Response to COVID-19 and Related Developments
    • 7.2 Merck
      • 7.2.1 Merck Business Overview
      • 7.2.2 Merck Veterinary Antibiotics Quarterly Production and Revenue, 2020
      • 7.2.3 Merck Veterinary Antibiotics Product Introduction
      • 7.2.4 Merck Response to COVID-19 and Related Developments
    • 7.3 Merial (Animal Health Division Of Sanofi)
      • 7.3.1 Merial (Animal Health Division Of Sanofi) Business Overview
      • 7.3.2 Merial (Animal Health Division Of Sanofi) Veterinary Antibiotics Quarterly Production and Revenue, 2020
      • 7.3.3 Merial (Animal Health Division Of Sanofi) Veterinary Antibiotics Product Introduction
      • 7.3.4 Merial (Animal Health Division Of Sanofi) Response to COVID-19 and Related Developments
    • 7.4 Elanco
      • 7.4.1 Elanco Business Overview
      • 7.4.2 Elanco Veterinary Antibiotics Quarterly Production and Revenue, 2020
      • 7.4.3 Elanco Veterinary Antibiotics Product Introduction
      • 7.4.4 Elanco Response to COVID-19 and Related Developments
    • 7.5 Bayer healthcare
      • 7.5.1 Bayer healthcare Business Overview
      • 7.5.2 Bayer healthcare Veterinary Antibiotics Quarterly Production and Revenue, 2020
      • 7.5.3 Bayer healthcare Veterinary Antibiotics Product Introduction
      • 7.5.4 Bayer healthcare Response to COVID-19 and Related Developments
    • 7.6 Ceva Animal Health, Inc.
      • 7.6.1 Ceva Animal Health, Inc. Business Overview
      • 7.6.2 Ceva Animal Health, Inc. Veterinary Antibiotics Quarterly Production and Revenue, 2020
      • 7.6.3 Ceva Animal Health, Inc. Veterinary Antibiotics Product Introduction
      • 7.6.4 Ceva Animal Health, Inc. Response to COVID-19 and Related Developments
    • 7.7 Virbac
      • 7.7.1 Virbac Business Overview
      • 7.7.2 Virbac Veterinary Antibiotics Quarterly Production and Revenue, 2020
      • 7.7.3 Virbac Veterinary Antibiotics Product Introduction
      • 7.7.4 Virbac Response to COVID-19 and Related Developments
    • 7.8 Boehringer Ingelheim
      • 7.8.1 Boehringer Ingelheim Business Overview
      • 7.8.2 Boehringer Ingelheim Veterinary Antibiotics Quarterly Production and Revenue, 2020
      • 7.8.3 Boehringer Ingelheim Veterinary Antibiotics Product Introduction
      • 7.8.4 Boehringer Ingelheim Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Veterinary Antibiotics Supply Chain Analysis
      • 8.1.1 Veterinary Antibiotics Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Veterinary Antibiotics Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Veterinary Antibiotics Distribution Channels
      • 8.2.2 Covid-19 Impact on Veterinary Antibiotics Distribution Channels
      • 8.2.3 Veterinary Antibiotics Distributors
    • 8.3 Veterinary Antibiotics Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Veterinary Antibiotics, including the following market information:
      Global Veterinary Antibiotics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Veterinary Antibiotics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Veterinary Antibiotics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Veterinary Antibiotics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Zoetis animal healthcare, Merck, Merial (Animal Health Division Of Sanofi), Elanco, Bayer healthcare, Ceva Animal Health, Inc., Virbac, Boehringer Ingelheim, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Tetracyclines
      Penicillins
      Macrolides
      Sulphonamides
      Aminoglycosides
      Others

      Based on the Application:
      Farm Animals
      Companion Animals

      Buy now